NJ-CRYPTOS-FUND
12.4.2018 17:03:05 CEST | Business Wire | Press release
Cryptos Fund , the first regulated cryptocurrency index fund, announces the launch of a new entity dedicated to qualified investors.
Cryptos Fund (US) is based in Princeton, NJ, and is managed by Hermes Asset Management, with a team lead by Igor Rivin, one of the world’s most respected mathematicians, and a professor of Mathematics at Temple University. The fund tracks the CCi30 index of the 30 main cryptocurrencies, thus allowing investors to gain exposure to the entire Blockchain sector.
“The blockchain sector is still in its infancy and has enormous growth potential,” says Dr. Igor Rivin, the Chief Research Officer. “Institutional investors have just started to enter this sector; we expect more and more players of the caliber of George Soros to join the field in the future. We believe that following the CCi30 index is a smart way to invest in cryptocurrencies. While we have no crystal ball, we feel that this is the most prudent way to explore the market.”
Jeffrey Zorn, the Chief Security Officer, says: “The fund is the best instrument for participating in the growth of cryptocurrencies and the blockchain technology, which is one of the three most important inventions of the last 50 years, together with silicon and the internet. Cryptos Fund provides the highest levels of security: counterparty risk has been completely neutralized, and the assets are held in our proprietary cold storage, with redundant facilities and military-level physical protection.” Jeffrey Zorn is a global security expert, Major, USMC, recipient of the Bronze Star Medal with Valor device, and former military aide to the U.S. president at the White House. In this role he carried the “football,” the briefcase containing the codes of the U.S. nuclear arsenal. Today Zorn consults multinational corporations and governments on security matters and is responsible for all the security aspects of Cryptos Fund.
The following top quality service providers are employed by the fund: Trident Trust, administrator; Baker Tilly, auditor; Morgan, Lewis & Bockius, legal advisor; and BMO Harris, banker.
Cryptos Fund accepts subscriptions from qualified investors starting from $10,000. It doesn’t charge subscription, redemption or performance fees, while the management fee is as low as 0.99%, depending on the size of the subscription.
Investors wishing to participate in Cryptos Fund (US) can visit www.thecryptos.fund .
View source version on businesswire.com: https://www.businesswire.com/news/home/20180412005867/en/
Contact:
Cryptos Fund
Ariel Schulz, +1.609.375.8508
info@thecryptosfund.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OpenAI and Yubico Partner to Bring Custom Phishing-Resistant YubiKeys to OpenAI Users30.4.2026 19:13:00 CEST | Press release
New strategic, long-term partnership with OpenAI delivers the gold standard of hardware-backed passkeys to the AI ecosystem Yubico (NASDAQ STOCKHOLM: YUBICO), the pioneer of phishing-resistant authentication and creator of the YubiKey, the gold standard of security keys, today announced an industry-first collaboration with OpenAI, the creator of ChatGPT. Beginning today, people can purchase a new 2-pack set of custom YubiKeys as part of OpenAI’s Advanced Account Security program – enabling them to secure their ChatGPT accounts with security keys, containing the strongest hardware-backed passkeys. Specifically designed for security-conscious users who are at increased risk of targeted digital attacks, the set includes a YubiKey C NFC for tap-to-authenticate on mobile, and a low profile YubiKey C Nano that stays in a port for everyday laptop use – both packed with modern authentication features for the highest level of protection. With OpenAI already using YubiKeys internally to protect
rhode Continues Its Global Retail Expansion Into Sephora Europe30.4.2026 18:00:00 CEST | Press release
This expansion into Sephora Europe increases global access to rhode through physical retail, marking a pivotal next stage for the brand rhode, the beauty brand founded by Hailey Rhode Bieber, will be available at Sephora online and in most stores across Europe beginning this September, following its 2025 rollout with Sephora in the U.S., Canada, and the U.K. This expansion into Sephora Europe increases global access to rhode through physical retail, marking a pivotal next stage for the brand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430569580/en/ rhode continues its global retail expansion into Sephora Europe. rhode’s collection of high-performance, skin-focused products saw strong performance in Sephora U.S. and Canada as the biggest brand launch in the retailer’s history in North America. When launched in November 2025 in the U.K., rhode was also the largest brand launch in Sephora U.K.’s history. “I’m so excited
ABS Acquires RMC Global to Strengthen Cyber, Risk and Resilience Capabilities30.4.2026 17:46:00 CEST | Press release
Acquisition to Deliver Stronger, More Integrated Solutions for Clients ABS, through its affiliate ABSG Consulting Inc. (ABS Consulting), has today announced the acquisition of RMC Global (RMC), a leading provider of industrial cybersecurity, risk management and resiliency solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430164690/en/ (L to R): Vince Kuchar, President, RMC Global, and David Wechsler, President and CEO, ABS Group The acquisition strengthens ABS Consulting’s capabilities and market position, bringing together two organizations with complementary expertise, shared values and a common mission. Combining RMC’s capabilities with ABS Consulting’s scale, technical depth and global resources, unlocks more integrated solutions for clients operating in increasingly complex risk environments. ABS Chairman and CEO John McDonald said: “Clients are facing increasing operational risk, cyber threats, and regulator
Brightfin Unveils AI-Native Platform for IT Financial Management30.4.2026 17:00:00 CEST | Press release
Brightfin clients drive their businesses forward with the first AI Native Cost Optimization Platform Brightfin, the only ITFM and Technology Expense Management solution built natively on ServiceNow, today announced an AI-Native architecture that fundamentally improves how organizations manage IT spend. Rather than bolting AI onto legacy systems, Brightfin has engineered intelligence from the ground up - starting with the data, building contextual awareness on top of it, and delivering AI agents that speak the language of IT finance. Brightfin’s unified budget-to-billing data model creates a stable, governed foundation that connects contracts, invoices, inventory, and budgets into a single source of truth - something no external ITFM tool or native platform module can replicate. This is a structured financial backbone purpose-built for enterprise IT spend, and it’s what makes everything above it possible. A context-aware, AI-Native, intelligence layer understands relationships across th
SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 202430.4.2026 15:22:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the “Annual Report”) with the U.S. Securities and Exchange Commission (“SEC”). An electronic copy of the Annual Report can be accessed on SINOVAC’s investor relations website at https://www.sinovac.com/en-us/Investors and on the SEC’s website at www.sec.gov. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of “supply vaccines to eliminate human diseases”, the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases. The company’s diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, et
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom